KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →
NEWExperts by KevinMDPhysicians and health care experts, by specialty.Bobby DuboisInternistSusan BennettPrimary care physicianFady Hannah-ShmouniEndocrinologistJessie MahoneyPediatricianJill BeckerAddiction physicianLynn R. WebsterPain medicine physicianEarl J. CampazziConcierge physicianJoseph Rucker Jr.Retired plastic surgeonPaul B. JohnsonOculoplastic surgeonDanny GoelOrthopedic surgeonDomenico SavattaUrologistMuhamad Aly RifaiPsychiatristJulian BailesNeurosurgeonCourtney Markham-AbediPsychiatristSameen FarooqInternistNathaniel AranaHealth care CEOSteve KaplanTechnology executiveJodie GreenNonprofit founderJennifer HessDisability attorneyBrowse experts

Pfizer: Going to the dogs

Having had setbacks with torcetrapib and Exubera, and with generic competition to Norvasc and Lipitor, Pfizer is putting more emphasis into animal drugs.

Share this articleLinkedInFacebookXEmail

Tagged as: Medications and Prescribing

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.

Keep reading

Latest on KevinMD →

View 1 Comments >
KevinMD.com
Pfizer: Going to the dogs
1
1